Monday, February 6, 2012 4:27 PM GMT
Lester wrote:
I came across this post Monday.
"Scientists for the Food and Drug Administration say an Amgen drug slowed the spread of cancer to the bone in men with hard-to-treat prostate cancer, though the drug failed to extend life and carried significant side effects."
Would anyone care to comment?
Posted by Lester Rios from Kansas City, MO
Monday, February 6, 2012 12:39 PM GMT
Posted by Travis Bates from Arlington, TX
Monday, February 6, 2012 10:26 AM GMT
Posted by Jim Mathis from Omaha, NE
Monday, February 6, 2012 9:38 AM GMT
Posted by Dale Williamson from El Monte, CA
Sunday, February 5, 2012 10:50 PM GMT
Every year, in the United States alone, around 185,000 men are diagnosed with some degree of prostate cancer. These new patients are in addition to the roughly five million previously diagnosed with the . . .
Posted by Jim Lindsey from Indianapolis, IN
Sunday, February 5, 2012 7:50 PM GMT
"There have been remarkable advances in the treatment of all cancers in the last twenty years, but for prostate cancer in particular, because it is rather a slow-growing one, particularly in the early . . ."
From WWW.GATHER.COM
Posted by Joshua Griffin from Buffalo, NY
Sunday, February 5, 2012 12:49 PM GMT
Posted by Manuel Lyons from Ann Arbor, MI
Saturday, February 4, 2012 5:36 PM GMT
Posted by Beth Bridges from Orlando, FL
Friday, February 3, 2012 9:34 PM GMT
My cousin, Louis,told me about this.
Posted by Derrick Parks from Boston, MA
Friday, February 3, 2012 2:46 PM GMT
Veronica wrote:
Did anyone else see this article?
"REDWOOD CITY, Calif., Feb. 3, 2012 /PRNewswire/ --?Genomic Health, Inc. (Nasdaq: GHDX - News) today announced results from a large clinical study in prostate cancer evaluating the relationship of microRNAs, a ..."
Posted by Veronica Barnett from Tampa, FL
Prostate Cancer Awareness RSS Feed